Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2022 Filed Oct 6, 2022 17:58 UTC |
SCHIFF ANDREW NDirector
|
SaleCommon Stock | 37,839 | $16.54 | $625,743.54 |
DisclosureSEC source: 0001209191-22-053003 · doc4.xml · nonDerivative · entry 2 SCHIFF ANDREW N · CIK 0001172252 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aisling Capital IV LP Disclosed balance after: 588,916 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Aisling Capital IV, LP on August 23, 2022. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are owned directly by Aisling Capital IV, LP ("Aisling"), and held indirectly by Aisling Capital Partners IV, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners IV LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners, and the Managers share voting and dispositive power over the shares directly held by Aisling. Dr. Schiff disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein. Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 17:58 UTC |
SCHIFF ANDREW NDirector
|
SaleCommon Stock | 7,700 | $16.01 | $123,258.52 |
DisclosureSEC source: 0001209191-22-053003 · doc4.xml · nonDerivative · entry 1 SCHIFF ANDREW N · CIK 0001172252 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aisling Capital IV LP Disclosed balance after: 626,755 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Aisling Capital IV, LP on August 23, 2022. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.00 to $16.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The reportable securities are owned directly by Aisling Capital IV, LP ("Aisling"), and held indirectly by Aisling Capital Partners IV, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners IV LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners, and the Managers share voting and dispositive power over the shares directly held by Aisling. Dr. Schiff disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:10 UTC |
Manion Douglas J.Pres and COO
|
GrantRestricted Stock Units · Derivative | 62,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-043928 · doc4.xml · derivative · entry 2 Manion Douglas J. · CIK 0001875875 · Pres and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,300 Underlying: Common Stock · 62,300 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F3 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on August 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F3 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on August 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:10 UTC |
Manion Douglas J.Pres and COO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 217,800 | $0.00 Strike: $13.62 | $0.00 |
DisclosureSEC source: 0001209191-22-043928 · doc4.xml · derivative · entry 1 Manion Douglas J. · CIK 0001875875 · Pres and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,800 Underlying: Common Stock · 217,800 shares Expires 2032-07-31 F1 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on August 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 21:01 UTC |
Cawkwell GailChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040787 · doc4.xml · derivative · entry 2 Cawkwell Gail · CIK 0001761167 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. F3 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on July 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. F3 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on July 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 21:01 UTC |
Cawkwell GailChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 210,000 | $0.00 Strike: $13.83 | $0.00 |
DisclosureSEC source: 0001209191-22-040787 · doc4.xml · derivative · entry 1 Cawkwell Gail · CIK 0001761167 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Underlying: Common Stock · 210,000 shares Expires 2032-06-30 F1 · derivative.exercise_date: Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on July 1, 2023, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 16:57 UTC |
SCHIFF ANDREW NDirector
|
SaleCommon Stock | 19,565 | $15.14 | $296,268.88 |
DisclosureSEC source: 0001209191-22-038451 · doc4.xml · nonDerivative · entry 1 SCHIFF ANDREW N · CIK 0001172252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2022. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 17:36 UTC |
SCHIFF ANDREW NDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034617 · doc4.xml · derivative · entry 5 SCHIFF ANDREW N · CIK 0001172252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F6 · derivative.exercise_date: The shares underlying these restricted stock units vested on June 3, 2022. F6 · derivative.expiration_date: The shares underlying these restricted stock units vested on June 3, 2022. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 17:36 UTC |
SCHIFF ANDREW NDirector
|
Exercise / conversionCommon Stock | 3,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034617 · doc4.xml · nonDerivative · entry 1 SCHIFF ANDREW N · CIK 0001172252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:18 UTC |
Humphries William D.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034585 · doc4.xml · derivative · entry 4 Humphries William D. · CIK 0001674278 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested on June 3, 2022. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested on June 3, 2022. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:18 UTC |
Humphries William D.Director
|
Exercise / conversionCommon Stock | 3,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034585 · doc4.xml · nonDerivative · entry 1 Humphries William D. · CIK 0001674278 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:15 UTC |
GOWEN MAXINEDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034582 · doc4.xml · derivative · entry 4 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested on June 3, 2022. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested on June 3, 2022. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:15 UTC |
GOWEN MAXINEDirector
|
Exercise / conversionCommon Stock | 3,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034582 · doc4.xml · nonDerivative · entry 1 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:24 UTC |
MILANO VINCENTDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034592 · doc4.xml · derivative · entry 4 MILANO VINCENT · CIK 0001187159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested on June 3, 2022. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested on June 3, 2022. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:24 UTC |
MILANO VINCENTDirector
|
Exercise / conversionCommon Stock | 3,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034592 · doc4.xml · nonDerivative · entry 1 MILANO VINCENT · CIK 0001187159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 17:30 UTC |
Powell Andrew Kenneth WilliamDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034601 · doc4.xml · derivative · entry 5 Powell Andrew Kenneth William · CIK 0001304113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested on June 3, 2022. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested on June 3, 2022. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 17:30 UTC |
Powell Andrew Kenneth WilliamDirector
|
Exercise / conversionCommon Stock | 3,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034601 · doc4.xml · nonDerivative · entry 2 Powell Andrew Kenneth William · CIK 0001304113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 17:33 UTC |
Reasons Bryan M.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034606 · doc4.xml · derivative · entry 4 Reasons Bryan M. · CIK 0001553489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested on June 3, 2022. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested on June 3, 2022. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 17:33 UTC |
Reasons Bryan M.Director
|
Exercise / conversionCommon Stock | 3,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034606 · doc4.xml · nonDerivative · entry 1 Reasons Bryan M. · CIK 0001553489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,565 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:27 UTC |
Molineaux Christopher P.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034596 · doc4.xml · derivative · entry 4 Molineaux Christopher P. · CIK 0001654773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested on June 3, 2022. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested on June 3, 2022. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:27 UTC |
Molineaux Christopher P.Director
|
Exercise / conversionCommon Stock | 3,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034596 · doc4.xml · nonDerivative · entry 1 Molineaux Christopher P. · CIK 0001654773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:21 UTC |
Mehra AnandDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,356 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034589 · doc4.xml · derivative · entry 4 Mehra Anand · CIK 0001590102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,356 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F5 · derivative.exercise_date: The shares underlying these restricted stock units vested on June 3, 2022. F5 · derivative.expiration_date: The shares underlying these restricted stock units vested on June 3, 2022. Read SEC document |
| June 03, 2022 Filed Jun 6, 2022 21:21 UTC |
Mehra AnandDirector
|
Exercise / conversionCommon Stock | 3,356 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034589 · doc4.xml · nonDerivative · entry 1 Mehra Anand · CIK 0001590102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 17:36 UTC |
SCHIFF ANDREW NDirector
|
GrantRestricted Stock Units · Derivative | 4,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034617 · doc4.xml · derivative · entry 4 SCHIFF ANDREW N · CIK 0001172252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,507 Underlying: Common Stock · 4,507 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F3 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F5 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. F5 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 17:36 UTC |
SCHIFF ANDREW NDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-22-034617 · doc4.xml · derivative · entry 3 SCHIFF ANDREW N · CIK 0001172252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 15,750 shares Expires 2032-06-01 F3 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:18 UTC |
Humphries William D.Director
|
GrantRestricted Stock Units · Derivative | 4,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034585 · doc4.xml · derivative · entry 3 Humphries William D. · CIK 0001674278 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,507 Underlying: Common Stock · 4,507 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:18 UTC |
Humphries William D.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-22-034585 · doc4.xml · derivative · entry 2 Humphries William D. · CIK 0001674278 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 15,750 shares Expires 2032-06-01 F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:15 UTC |
GOWEN MAXINEDirector
|
GrantRestricted Stock Units · Derivative | 4,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034582 · doc4.xml · derivative · entry 3 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,507 Underlying: Common Stock · 4,507 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:15 UTC |
GOWEN MAXINEDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-22-034582 · doc4.xml · derivative · entry 2 GOWEN MAXINE · CIK 0001280044 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 15,750 shares Expires 2032-06-01 F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:24 UTC |
MILANO VINCENTDirector
|
GrantRestricted Stock Units · Derivative | 4,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034592 · doc4.xml · derivative · entry 3 MILANO VINCENT · CIK 0001187159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,507 Underlying: Common Stock · 4,507 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:24 UTC |
MILANO VINCENTDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-22-034592 · doc4.xml · derivative · entry 2 MILANO VINCENT · CIK 0001187159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 15,750 shares Expires 2032-06-01 F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 17:30 UTC |
Powell Andrew Kenneth WilliamDirector
|
GrantRestricted Stock Units · Derivative | 4,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034601 · doc4.xml · derivative · entry 4 Powell Andrew Kenneth William · CIK 0001304113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,507 Underlying: Common Stock · 4,507 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 17:30 UTC |
Powell Andrew Kenneth WilliamDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-22-034601 · doc4.xml · derivative · entry 3 Powell Andrew Kenneth William · CIK 0001304113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 15,750 shares Expires 2032-06-01 F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 17:33 UTC |
Reasons Bryan M.Director
|
GrantRestricted Stock Units · Derivative | 4,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034606 · doc4.xml · derivative · entry 3 Reasons Bryan M. · CIK 0001553489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,507 Underlying: Common Stock · 4,507 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 17:33 UTC |
Reasons Bryan M.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-22-034606 · doc4.xml · derivative · entry 2 Reasons Bryan M. · CIK 0001553489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 15,750 shares Expires 2032-06-01 F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:27 UTC |
Molineaux Christopher P.Director
|
GrantRestricted Stock Units · Derivative | 4,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034596 · doc4.xml · derivative · entry 3 Molineaux Christopher P. · CIK 0001654773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,507 Underlying: Common Stock · 4,507 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:27 UTC |
Molineaux Christopher P.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-22-034596 · doc4.xml · derivative · entry 2 Molineaux Christopher P. · CIK 0001654773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 15,750 shares Expires 2032-06-01 F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:21 UTC |
Mehra AnandDirector
|
GrantRestricted Stock Units · Derivative | 4,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034589 · doc4.xml · derivative · entry 3 Mehra Anand · CIK 0001590102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,507 Underlying: Common Stock · 4,507 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F4 · derivative.exercise_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. F4 · derivative.expiration_date: The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:21 UTC |
Mehra AnandDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,750 | $0.00 Strike: $14.48 | $0.00 |
DisclosureSEC source: 0001209191-22-034589 · doc4.xml · derivative · entry 2 Mehra Anand · CIK 0001590102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,750 Underlying: Common Stock · 15,750 shares Expires 2032-06-01 F2 · derivative.exercise_date: This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy. F3 · derivative.exercise_date: The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date. Read SEC document |
| May 16, 2022 Filed Jun 6, 2022 17:30 UTC |
Powell Andrew Kenneth WilliamDirector
|
GiftCommon Stock | 709 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034601 · doc4.xml · nonDerivative · entry 1 Powell Andrew Kenneth William · CIK 0001304113 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,500 Read SEC document |
| April 25, 2022 Filed Apr 25, 2022 21:13 UTC |
Walker NealDirector · President and CEO
|
SaleCommon Stock | 20,000 | $15.18 | $303,656.00 |
DisclosureSEC source: 0001209191-22-025537 · doc4.xml · nonDerivative · entry 3 Walker Neal · CIK 0001604457 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,245,763 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2022. F4 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 22, 2022 Filed Apr 25, 2022 21:13 UTC |
Walker NealDirector · President and CEO
|
SaleCommon Stock | 25,000 | $15.04 | $376,097.50 |
DisclosureSEC source: 0001209191-22-025537 · doc4.xml · nonDerivative · entry 2 Walker Neal · CIK 0001604457 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,265,763 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2022. F3 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 21:13 UTC |
Walker NealDirector · President and CEO
|
SaleCommon Stock | 25,000 | $15.24 | $380,947.50 |
DisclosureSEC source: 0001209191-22-025537 · doc4.xml · nonDerivative · entry 1 Walker Neal · CIK 0001604457 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,290,763 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2022. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 17:06 UTC |
Monahan JosephChief Scientific Officer
|
SaleCommon Stock | 30,000 | $16.28 | $488,298.00 |
DisclosureSEC source: 0001209191-22-025032 · doc4.xml · nonDerivative · entry 1 Monahan Joseph · CIK 0001861790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,386 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2022. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.84 to $16.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 20:58 UTC |
Walker NealDirector · President and CEO
|
SaleCommon Stock | 56,303 | $15.91 | $896,045.35 |
DisclosureSEC source: 0001209191-22-018516 · doc4.xml · nonDerivative · entry 1 Walker Neal · CIK 0001604457 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,315,763 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 1, 2022 and March 2, 2022 pursuant to preexisting sell-to-cover elections. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.72 to $16.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 16:53 UTC |
Monahan JosephChief Scientific Officer
|
SaleCommon Stock | 27,165 | $15.71 | $426,802.90 |
DisclosureSEC source: 0001209191-22-018501 · doc4.xml · nonDerivative · entry 1 Monahan Joseph · CIK 0001861790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,386 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 1, 2022 and March 2, 2022 pursuant to preexisting sell-to-cover elections. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.22 to $16.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:56 UTC |
Ruffo FrankChief Financial Officer
|
SaleCommon Stock | 12,823 | $15.55 | $199,334.82 |
DisclosureSEC source: 0001209191-22-018509 · doc4.xml · nonDerivative · entry 1 Ruffo Frank · CIK 0001654450 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,883 F1 · kind: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on March 1, 2022 and March 2, 2022 pursuant to preexisting sell-to-cover elections. F2 · price: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.22 to $16.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 18:11 UTC |
Monahan JosephChief Scientific Officer
|
Exercise / conversionRestricted stock units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015829 · doc4.xml · derivative · entry 9 Monahan Joseph · CIK 0001861790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F6 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date. F6 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 18:11 UTC |
Monahan JosephChief Scientific Officer
|
Exercise / conversionCommon Stock | 12,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-015829 · doc4.xml · nonDerivative · entry 3 Monahan Joseph · CIK 0001861790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 23:08 UTC |
Ruffo FrankChief Financial Officer
|
Exercise / conversionRestricted stock units · Derivative | 8,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015809 · doc4.xml · derivative · entry 8 Ruffo Frank · CIK 0001654450 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,595 Underlying: Common Stock · 8,297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. F6 · derivative.exercise_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date. F6 · derivative.expiration_date: The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.